Survey COVID-19 among the homeless residents of Isin camp in Bandar Abbas in South of Iran.
COVID-19
homeless
screening
Journal
Journal of education and health promotion
ISSN: 2277-9531
Titre abrégé: J Educ Health Promot
Pays: India
ID NLM: 101593794
Informations de publication
Date de publication:
2021
2021
Historique:
received:
26
12
2020
accepted:
06
03
2021
entrez:
2
3
2022
pubmed:
3
3
2022
medline:
3
3
2022
Statut:
epublish
Résumé
One way to reduce the burden of early detection of COVID-19 disease is in vulnerable and high-risk groups. The aim of this study was to diagnose and evaluate the disease in the homeless in Southern Iran Bandar Abbas. The target group of this study was 234 homeless people. Census sampling included all homeless residents of Isin camp Bandar Abbas. People were individually examined, and their information was recorded. COVID-19 sampling was done for all as outpatients this year. Eight percent of people were able to answer the questions of awareness about symptoms, ways of transmission, and ways of prevention of COVID-19 disease. Nine percent of the homeless people in the target group stated that they used to wash their hands before settling in the camp. Six percent of homeless people stated that they used face masks before settling in the camp. Fifteen participants showed similar symptoms to COVID-19, yet their test result was negative. However, six people who were asymptomatic ended up afflicted. The mean duration of time (since the emergence of symptoms to the sampling date) was 3 days. The minimum duration of time from the emergence of symptoms to the sampling date was 3 h, and the maximum time was 7 days. Considering the spread of the disease, certain social measures need to be taken in society to help take care of these people and transfer them from streets to safe places and provide for their essentials. Diagnostic tests should be done periodically among these people at regular intervals.
Sections du résumé
BACKGROUND
BACKGROUND
One way to reduce the burden of early detection of COVID-19 disease is in vulnerable and high-risk groups. The aim of this study was to diagnose and evaluate the disease in the homeless in Southern Iran Bandar Abbas.
MATERIALS AND METHODS
METHODS
The target group of this study was 234 homeless people. Census sampling included all homeless residents of Isin camp Bandar Abbas. People were individually examined, and their information was recorded. COVID-19 sampling was done for all as outpatients this year.
RESULTS
RESULTS
Eight percent of people were able to answer the questions of awareness about symptoms, ways of transmission, and ways of prevention of COVID-19 disease. Nine percent of the homeless people in the target group stated that they used to wash their hands before settling in the camp. Six percent of homeless people stated that they used face masks before settling in the camp. Fifteen participants showed similar symptoms to COVID-19, yet their test result was negative. However, six people who were asymptomatic ended up afflicted. The mean duration of time (since the emergence of symptoms to the sampling date) was 3 days. The minimum duration of time from the emergence of symptoms to the sampling date was 3 h, and the maximum time was 7 days.
CONCLUSION
CONCLUSIONS
Considering the spread of the disease, certain social measures need to be taken in society to help take care of these people and transfer them from streets to safe places and provide for their essentials. Diagnostic tests should be done periodically among these people at regular intervals.
Identifiants
pubmed: 35233405
doi: 10.4103/jehp.jehp_1664_20
pii: JEHP-10-458
pmc: PMC8826890
doi:
Types de publication
Journal Article
Langues
eng
Pagination
458Informations de copyright
Copyright: © 2021 Journal of Education and Health Promotion.
Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
Int J Tuberc Lung Dis. 2020 May 1;24(5):550-552
pubmed: 32398216
Cochrane Database Syst Rev. 2020 Apr 8;4:CD013574
pubmed: 32267544
Int J Drug Policy. 2019 Jan;63:90-96
pubmed: 30513474
Lancet. 2020 Mar 28;395(10229):1015-1018
pubmed: 32197103
EMBO Mol Med. 2020 May 8;12(5):e12481
pubmed: 32275804
Ann Acad Med Singap. 2020 Jan;49(3):155-160
pubmed: 32200399
Lancet. 2020 Mar 21;395(10228):949
pubmed: 32087125
Euro Surveill. 2020 Apr;25(13):
pubmed: 32265005
JAMA. 2020 May 19;323(19):1915-1923
pubmed: 32275295
J Travel Med. 2020 Mar 13;27(2):
pubmed: 32052841